HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

TECH — Bio-Techne Corp

TECH (Bio-Techne Corp) stock: $72.78, $11.41B market cap, $264.7M cash, $11.15B EV, $12.02B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

Our broad product portfolio and application expertise enables scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. Our products aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.

Source: 10-K FY2026 via SEC EDGAR

Share price
$72.78
Market cap
$11,413.2M
Cash
$264.7M
Enterprise value
$11,148.5M

Balance sheet

Cash$264.7M
Debt$0.0M
Net cash$264.7M
Enterprise value$11,148.5M
Basic shares157.1M shares
Fully diluted shares165.2M shares
Fully diluted market cap$12,022.7M
Cash per share$1.69
Quarterly burn+$95.4M generated

Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.

Share structure

Common
157.1M
Pre-funded warrants
0.0M
Options
7.1M
RSUs
1.0M
Warrants
0.0M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
—
FDSO
165.2M

Cap table as of 2026-06-30.

Price history

Loading TECH daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego